C34 Stock Overview
Provides cloud based electronic health record solutions to the health care industry in Sweden, Norway, and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
Carasent ASA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NOK 1.56 |
52 Week High | NOK 1.64 |
52 Week Low | NOK 0.84 |
Beta | 0.47 |
11 Month Change | -0.64% |
3 Month Change | 70.31% |
1 Year Change | 26.62% |
33 Year Change | -52.29% |
5 Year Change | n/a |
Change since IPO | -27.44% |
Recent News & Updates
Recent updates
Shareholder Returns
C34 | DE Healthcare Services | DE Market | |
---|---|---|---|
7D | 2.3% | -1.5% | 0.6% |
1Y | 26.6% | -25.9% | 3.3% |
Return vs Industry: C34 exceeded the German Healthcare Services industry which returned -25.9% over the past year.
Return vs Market: C34 exceeded the German Market which returned 3.3% over the past year.
Price Volatility
C34 volatility | |
---|---|
C34 Average Weekly Movement | 13.7% |
Healthcare Services Industry Average Movement | 3.8% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.4% |
10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: C34's share price has been volatile over the past 3 months.
Volatility Over Time: C34's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | 165 | Daniel Ohman | carasent.com |
Carasent ASA provides cloud based electronic health record solutions to the health care industry in Sweden, Norway, and internationally. The company offers Webdoc, a cloud-based EHR system; Metodika EPM, a solution designed for mid-to-large-sized organizations; Medrave M4 to give healthcare staff and managers an overview and clear picture of the patient group being treated; Health Profile Institute AB (HPI), an occupational care platform; Ad Curis, a record system with digital services tailored for the specialist healthcare service with clients in rehabilitation, interdisciplinary specialized drug treatment, and mental health care, as well as businesses in care and prevention; and Ad Opus, a journal system for follow-up of participants in measures. It also provides platform services, such as Vårdrummet, Confrere, Ad Voca, electronic letters, SMS services, portal to medical services, and consulting and other services.
Carasent ASA Fundamentals Summary
C34 fundamental statistics | |
---|---|
Market cap | €114.86m |
Earnings (TTM) | -€4.90m |
Revenue (TTM) | €21.96m |
5.2x
P/S Ratio-23.5x
P/E RatioIs C34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
C34 income statement (TTM) | |
---|---|
Revenue | NOK 250.95m |
Cost of Revenue | NOK 45.08m |
Gross Profit | NOK 205.87m |
Other Expenses | NOK 261.83m |
Earnings | -NOK 55.96m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 12, 2024
Earnings per share (EPS) | -0.77 |
Gross Margin | 82.04% |
Net Profit Margin | -22.30% |
Debt/Equity Ratio | 0% |
How did C34 perform over the long term?
See historical performance and comparison